Literature DB >> 20101183

(99m)Technetium-macroaggregated albumin perfusion lung scan versus contrast enhanced echocardiography in the diagnosis of the hepatopulmonary syndrome in children with chronic liver disease.

Mortada Hassan El-Shabrawi1, Salwa Omran, Shereine Wageeh, Mona Isa, Sawsan Okasha, Nabil A Mohsen, Ola Zekry, Gamal E-Bartan, Hanaa M El-Karaksy.   

Abstract

BACKGROUND AND AIMS: The hepatopulmonary syndrome (HPS) is a triad of advanced chronic liver disease (CLD), arterial hypoxemia and intrapulmonary arteriovenous shunting in the absence of a primary cardiopulmonary disease. HPS has been more frequently reported in adults than in children with no data on its prevalence in children with CLD. The aim of this study was to detect the prevalence of the HPS in a cohort of children with CLD because of chronic hepatitis B and/or C virus infection, schistosomiasis as well as inborn metabolic errors. We also aimed to evaluate the role of Technetium labeled macroaggregated albumin (Tc--MAA) perfusion lung scan versus contrast enhanced echocardiography (CEE) with intravenous injection of agitated saline in the diagnosis and quantification of intrapulmonary shunts and their relationship to important clinical and laboratory findings.
METHODS: Forty Egyptian children (22 males) were investigated. Their ages ranged from 5 to 12 years (with a mean of 9.5 years). Twenty individuals proved to have cirrhosis.
RESULTS: Blood gas determination revealed more significant arterial hypoxemia in cirrhotics than noncirrhotics both under room air and after breathing 100% oxygen for 15 mins. CEE showed comparable cardiac measurements in cirrhotic and noncirrhotic patients, and diagnosed intrapulmonary shunts in three hypoxemic cirrhotic patients; whereas Tc--MAAperfusion lung scan diagnosed shunts in seven patients (five of them cirrhotic). The presence of shunts was significantly correlated with the duration of CLD, clinical findings, presence of cirrhosis and porto-systemic collaterals. We calculated for each patient a shunt index (SI) by the formula: (activity outside thorax/activity outside plus inside thorax) 100; and an SI value of 0.278 was found to be a cutoff value for shunt detection. All patients with SI above this value had shunting associated with hypoxemia and all patients with SI below this value had no hypoxemia (specificity 100%).
CONCLUSION: Arterial hypoxemia and intrapulmonary shunts were diagnosed in 17.5% of this cohort of children with cirrhotic or noncirrhotic CLD representing the classic HPS. Tc--MAA perfusion lung scan was more sensitive than CEE in detection of intrapulmonary shunts. SI cutoff value of 0.278 was found to be highly specific for shunt detection and we recommend its validation in further studies.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20101183     DOI: 10.1097/MEG.0b013e328336562e

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  11 in total

Review 1.  Hepatopulmonary Syndrome.

Authors:  Yong Lv; Daiming Fan
Journal:  Dig Dis Sci       Date:  2015-03-03       Impact factor: 3.199

Review 2.  Hepatopulmonary syndrome: update on pathogenesis and clinical features.

Authors:  Junlan Zhang; Michael B Fallon
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-07-03       Impact factor: 46.802

3.  Hepatopulmonary Syndrome and Portopulmonary Hypertension: Current Status and Implications for Liver Transplantation.

Authors:  Kelley Weinfurtner; Kimberly Forde
Journal:  Curr Hepatol Rep       Date:  2020-07-11

4.  Unexplained cyanosis revealing hepatopulmonary syndrome in a child with asymptomatic congenital hepatic fibrosis: a case report.

Authors:  Atqah Abdul Wahab; Maryam Al-Mansoori; Mariam El-Hawli; Vishwanatha Kini
Journal:  J Med Case Rep       Date:  2013-04-29

5.  Pulmonary vascular complications of chronic liver disease: Pathophysiology, imaging, and treatment.

Authors:  Ali Nawaz Khan; Hamdan Al-Jahdali; Khalid Abdullah; Klaus L Irion; Quratulain Sabih; Alaa Gouda
Journal:  Ann Thorac Med       Date:  2011-04       Impact factor: 2.219

6.  Epstein-Barr virus hepatitis can cause transient hepatopulmonary syndrome.

Authors:  Seiyed Mohammad Ali Ghayumi; Maryam Rohani; Sajad Hasanzadeh; Shahrokh Sadeghi; Amrollah Roozbehi; Saeid Jokar
Journal:  Respir Med Case Rep       Date:  2018-04-03

7.  Hepatopulmonary Syndrome with Right-to-left Shunt in Cirrhotic Patients Using Macro-Aggregated Albumin Lung Perfusion Scan: Comparison with Contrast Echocardiography and Association with Clinical Data

Authors:  Zeynab Alipour; Abbas Armin; Sudabeh Mohamadi; Seyed Masoud Tabib; Zahra Azizmohammadi; Ali Gholamrezanezhad; Majid Assadi
Journal:  Mol Imaging Radionucl Ther       Date:  2020-02-17

Review 8.  Pulmonary manifestations of chronic liver disease: a comprehensive review.

Authors:  Stergios Soulaidopoulos; Ioannis Goulis; Evangelos Cholongitas
Journal:  Ann Gastroenterol       Date:  2020-03-27

9.  Clinical outcomes and risk factors of hepatopulmonary syndrome in children.

Authors:  Kwang Yeon Kim; Tae Hyeong Kim; Jeong-Moo Lee; Nam-Joon Yi; Hyun-Young Kim; Jin Soo Moon; Jae Sung Ko
Journal:  Sci Rep       Date:  2021-02-18       Impact factor: 4.379

10.  Intrapulmonary vascular dilatation evaluated by 99mTc-MAA scintigraphy and its association with portal hypertension in schistosomiasis.

Authors:  Andréa Simone Siqueira de Queirós; Simone Cristina Soares Brandão; Ana Lúcia Coutinho Domingues; Liana Gonçalves Macedo; Maira Souto Ourem; Edmundo Pessoa Almeida Lopes
Journal:  PLoS Negl Trop Dis       Date:  2014-06-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.